OptimizeRx Corporation (OPRX) Market Cap & Valuation Ratios
OptimizeRx Corporation (OPRX) has a market cap of $172.3M and a price-to-sales ratio of 1.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OPRXOptimizeRx CorporationFollow OPRX — free
—
Price chart with a free account
- Market cap
- 172.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Peers
health information services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| OPRX | 0.2 | — | 1.7 | 11.0 | 10.6% | -6% | 11% | 6% |
| TDOC | 1.2 | — | 0.6 | 7.7 | 11.4% | -2% | -8% | -11% |
| HSTM | 1.0 | 48.8 | 3.0 | 13.7 | 4.0% | +9% | 8% | 7% |
| PHR | 0.8 | 74.7 | 1.5 | 15.7 | 8.6% | +13% | 2% | 3% |
| SDGR | 0.6 | — | 0.7 | — | — | +9% | -59% | -187% |
| WEAV | 0.6 | — | 2.1 | — | 1.9% | +17% | -8% | -60% |
| EVH | 0.5 | — | 0.7 | — | 4.5% | -5% | -20% | -33% |
| NRC | 0.5 | 88.9 | 4.1 | 24.5 | 4.5% | -0.2% | 11% | 10% |
| SPOK | 0.2 | 18.1 | 1.5 | 10.0 | 11.8% | -3% | 12% | 9% |
| HCAT | 0.1 | — | 0.6 | — | 6.2% | -8% | -84% | -128% |
| DH | 0.1 | — | 0.4 | — | 24.8% | -5% | -105% | -181% |
| Median of these 10 | 61.8 | 1.1 | 13.7 | 6.2% | -1% | -8% | -22% |
; EV/Sales 1.7 vs. 1.1.
Growth vs. price
each dot a company · hover or tap for valuesOPRX and TDOC and SDGR and WEAV and EVH and HCAT and DH have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
OptimizeRx Corporation — questions
- What is OptimizeRx Corporation's market cap?
- $172.3M.
- What is OptimizeRx Corporation's price-to-sales ratio?
- 1.8.
Every figure on this page comes from OptimizeRx Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.